In an exciting development for the future of sports entertainment, Overtime has successfully raised $100 million in its latest funding round. Known for its innovative approach to building disruptive new sports leagues and intellectual property, Overtime is revolutionizing how the next generation of fans and athletes engage with sports. The company operates a range of high-energy leagues, including OTE and Overtime Select in basketball, OT7 in football, and OTX in boxing, effectively tapping into a massive and growing online audience. With a robust digital-first content strategy, Overtime boasts a community of over 100 million fans and followers, making it a significant player in the sports industry. This new funding will aid in expanding the reach of its brands, enhancing its existing digital content, and accelerating development across various platforms, allowing Overtime to continually engage its audience in fresh and exciting ways. Backed by industry heavyweights such as Liberty Media Corporation, Andreessen Horowitz, and Drake, along with over 40 NBA and NFL stars, including legends like Kevin Durant and Carmelo Anthony, Overtime is well-positioned to redefine the sports landscape. The company’s diverse business model—which includes sponsorships, e-commerce, and media rights—further strengthens its foundation for sustainable growth. As Overtime prepares for its next chapter, interested candidates can explore open positions within this dynamic company at [Overtime's careers page](https://www.teamworkonline.com/sports-technology-jobs/Overtime-overtime-elite-jobs/overtime).

Overtime Secures $100 Million in Funding from Leading Investors for Global Sports Expansion Plans
Get the full Overtime company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
InflaRx
InflaRx (Nasdaq: IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and commercialize highly potent and specific inhibitors of the complement activation factor C5a and its receptor C5aR. C5a is a powerful inflammatory mediator involved in the progression of a wide variety of inflammatory diseases. InflaRx’s lead product candidate, vilobelimab, is a novel, intravenously delivered, first-in-class, anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical studies in different indications. InflaRx is also developing INF904, an orally administered, small molecule inhibitor of the C5a receptor. InflaRx was founded in 2007, and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI, USA. For further information, please visit www.inflarx.com
$150.0M Unknown
today

Lunar Outpost
Lunar Outpost is the industry leader in commercial space robotics, lunar surface mobility, and in-space infrastructure. We are on a mission to enable an extended human presence in space while utilizing the vast resources in space to drive positive impacts here on Earth. From our five rovers headed to the Moon to explore, prospect, and establish infrastructure, to the creation of oxygen on Mars, our impact spans the solar system. Lunar Outpost’s mobility and robotic systems, ranging from our exploration-class Mobile Autonomous Prospecting Platform (MAPP) rover to our truck-sized industrial Lunar Terrain Vehicle (LTV), will be the workforce for the New Space economy and enable Lunar Outpost to bring the infinite value of space to benefit humanity on Earth and beyond. Through notable commercialization and amazing partnerships, Lunar Outpost creates tremendous value in the New Space economy. Lunar Outpost leads the Lunar Dawn team, consisting of General Motors, Goodyear, and MDA Space – the leading consortium for LTV providing mobility for Artemis astronauts, a critical component of the broader Artemis campaign that will enable a sustainable presence on the Moon. Lunar Outpost’s five upcoming lunar surface missions will make history, with our first rover set to be the first commercial rover on the Moon and the first rover in history to explore the lunar South Pole, while enabling the first sale of space resources in human history alongside many other firsts. Each of our next four rover voyages build on our capabilities and technology, all leading towards mobility and robotic systems that can reliably operate in the most extreme environments our solar system has to offer.
$30.0M Series b
today

Darkhive
Darkhive develops US-produced open autonomous robotics systems for the defense and public safety communities.
$30.0M Series b
today

Founders First Capital Partners
National lender serving BIPOC, veteran, LGBTQ+, & women-owned businesses, as well as businesses in LMI zones & those committed to diverse hiring practices. Helping accelerate business growth through our Revenue-Based Funding products & Advisory Services. Together, we can create more jobs, increase your revenues and bottom line, and provide more growth capital to help your business. We’re backed by the nation’s top philanthropic organizations, so that we can fund you with the right capital.
$3.9M Unknown
today

Nelson
We help companies reduce their carbon footprints, control their mobility costs and use energy more efficiently. Our data-driven software enables companies to plan, deploy and operate a successful electrification strategy for their car fleet. Nelson combines companies' fleet data and the charging ecosystem data to provide personalized recommendations -in real time & automatically.
$3.5M Seed
today